{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:34:58Z","timestamp":1790696098417,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To estimate the rate of retinal detachment (RD) after acute retinal necrosis (ARN) and evaluate the efficacies of different interventions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The databases Medline and EMBASE from inception to March 2020 were searched to identify the relevant studies. R software version 3.6.3 was used to perform the statistical analyses. Results in proportion with 95% confidence interval were calculated using generalized linear mixed models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Sixty-seven studies involving 1,811 patients were finally included. The pooling results suggested the general RD rate of ARN was 47%. The RD rate increased with the extent of retinitis and was slightly lower when involved Zone III. The RD rate was 37% for herpes simplex virus ARN and 46% for varicella\u2013zoster virus ARN; 52% for immunocompetent patients and 39% for immunocompromised patients. Retinal detachment presented in 2% of eyes at the first visit. Systemic antiviral therapy could lower the RD rate significantly from 67% to 43%, and prophylactic vitrectomy could lower the RD rate significantly from 45% to 22%. Systemic antiviral therapy plus vitrectomy achieved the lowest RD rate to 18%. Although the efficacy of prophylactic laser or intravitreal antiviral therapy was still limited. Prophylactic vitrectomy might significantly increase the incidence of proliferative vitreoretinopathy from 7% to 32%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>About half of the eyes might develop RD during the entire course of ARN. Systemic antiviral therapy and prophylactic vitrectomy are effective interventions to prevent RD, whereas the roles of prophylactic laser or adjunctive intravitreal antiviral therapy are still unclear. Varicella\u2013zoster virus ARN and cases with extensive retinitis might need intensified interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002971","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T08:01:53Z","timestamp":1600156913000},"page":"965-978","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":48,"title":["RETINAL DETACHMENT AFTER ACUTE RETINAL NECROSIS AND THE EFFICACIES OF DIFFERENT INTERVENTIONS"],"prefix":"10.1097","volume":"41","author":[{"given":"Xin-Yu","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China; and"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hui","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China; and"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China; and"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China; and"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China; and"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/bjo.2007.114884","article-title":"Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK","volume":"91","author":"Muthiah","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/eye.2011.338","article-title":"Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study","volume":"26","author":"Cochrane","year":"2012","journal-title":"Eye (Lond)"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ophtha.2006.08.037","article-title":"Acute retinal necrosis features, management, and outcomes","volume":"114","author":"Lau","year":"2007","journal-title":"Ophthalmology"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/IIO.0b013e31803777bb","article-title":"Acute retinal necrosis: an overview","volume":"47","author":"Chang","year":"2007","journal-title":"Int Ophthalmol Clin"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ophtha.2016.11.007","article-title":"Diagnosis and treatment of acute retinal necrosis: a report by the American Academy of Ophthalmology","volume":"124","author":"Schoenberger","year":"2017","journal-title":"Ophthalmology"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-9394(14)76725-X","article-title":"Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy","volume":"112","author":"Palay","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.ophtha.2009.03.029","article-title":"Acute retinal necrosis: clinical features, early vitrectomy, and outcomes","volume":"116","author":"Hillenkamp","year":"2009","journal-title":"Ophthalmology"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/postgradmedj-2012-301983rep","article-title":"Emerging concepts in the management of acute retinal necrosis","volume":"89","author":"Wong","year":"2013","journal-title":"Postgrad Med J"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.ophtha.2006.05.063","article-title":"Primary treatment of acute retinal necrosis with oral antiviral therapy","volume":"113","author":"Emerson","year":"2006","journal-title":"Ophthalmology"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ophtha.2006.06.058","article-title":"Treatment of acute retinal necrosis syndrome with oral antiviral medications","volume":"114","author":"Aizman","year":"2007","journal-title":"Ophthalmology"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2415-12-48","article-title":"Valacyclovir in the treatment of acute retinal necrosis","volume":"12","author":"Taylor","year":"2012","journal-title":"BMC Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/IAE.0b013e3181c7013c","article-title":"Long-term follow-up of acute retinal necrosis","volume":"30","author":"Meghpara","year":"2010","journal-title":"Retina"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3928\/23258160-20140908-02","article-title":"Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome","volume":"45","author":"Yeh","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ophtha.2009.08.003","article-title":"Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome","volume":"117","author":"Wong","year":"2010","journal-title":"Ophthalmology"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2019.05.023","article-title":"Risk of rhegmatogenous retinal detachment in acute retinal necrosis with and without prophylactic intervention","volume":"206","author":"Risseeuw","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12886-018-0674-9","article-title":"The necessity and optimal time for performing pars plana vitrectomy in acute retinal necrosis patients","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjo.75.5.292","article-title":"Acute retinal necrosis syndrome","volume":"75","author":"Gartry","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/IAE.0000000000002341","article-title":"Bilateral acute retinal necrosis: a case series","volume":"40","author":"Lei","year":"2020","journal-title":"Retina"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajo.2019.08.007","article-title":"Acute retinal necrosis: virological features using quantitative polymerase chain reaction, therapeutic management, and clinical outcomes","volume":"208","author":"Hafidi","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-6420(88)32999-4","article-title":"Photocoagulation to prevent retinal detachment in acute retinal necrosis","volume":"95","author":"Sternberg","year":"1988","journal-title":"Ophthalmology"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0039-6257(91)90183-G","article-title":"Diagnosis and management of the acute retinal necrosis (ARN) syndrome","volume":"35","author":"Duker","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41433-019-0587-8","article-title":"Ultra-wide-field fundus imaging of acute retinal necrosis: clinical characteristics and visual significance","volume":"34","author":"Lei","year":"2019","journal-title":"Eye (Lond)"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/09273948.2015.1115081","article-title":"Correlation of clinical outcomes with quantitative polymerase chain reaction DNA copy number in patients with acute retinal necrosis","volume":"25","author":"Calvo","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ophtha.2009.09.001","article-title":"Treatment of acute retinal necrosis","volume":"117","author":"Tibbetts","year":"2010","journal-title":"Ophthalmology"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08820530802111192","article-title":"Therapy for acute retinal necrosis","volume":"23","author":"Kawaguchi","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1120672118787438","article-title":"Clinical feature and visual prognosis of acute retinal necrosis according to the initially involved zone and extent: 10-year experience","volume":"29","author":"Kim","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/bjo.2008.147181","article-title":"Prophylactic laser photocoagulation for acute retinal necrosis. Does it raise more questions than answers?","volume":"92","author":"Park","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.1987.01060080053027","article-title":"Laser photocoagulation in the acute retinal necrosis syndrome","volume":"105","author":"Han","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/OPTH.S111893","article-title":"Intravitreal methotrexate infusion for proliferative vitreoretinopathy","volume":"10","author":"Sadaka","year":"2016","journal-title":"Clin Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:06:26Z","timestamp":1749319586000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002971"}},"subtitle":["A Systematic Review and Metaanalysis"],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002971","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}